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Introduction 
    In the last decade, diabetes has been a more 
important disease to be managed adequately in the 
world [1]. It is necessary to evaluate the status of 
diabetic patients concerning the presence of micro- 
and macroangiopathy, such as neuropathy, 
retinopathy, nephropathy, and arterial sclerosis [2]. 
These include Type 1 and 2 diabetes mellitus (T1DM, 
T2DM). As regards to diet therapy, there has been a 
variety of nutritional treatments reported so far. These 
are low-carbohydrate diet (LCD), calorie restriction 
(CR) (low-fat), Mediterranean, vegetarian, moderate 
carbohydrate, high-protein, low glycemic index/ 
glycemic load (GI/GL), Palaeolithic, control, and  
others [3]. 
Abstract 
    Authors and collaborators have continued diabetic practice and research on low carbohydrate diet (LCD), 
continuous glucose monitoring (CGM), and so on. The case is a 64-year-old male with type 2 diabetes mellitus 
(T2DM) treated with multiple daily insulin injections (MDI). When his HbA1c was 8.2% before, he changed to 
take tofu instead of rice and bread. HbA1c decreased to 7.1% and 4kg of weight reduction in 2 months. Tofu is a 
traditional Japanese food made from soybeans, which is a suitable LCD with Protein:Fat:Carbohydrate (PFC)   
ratio=40:45:15 in this case. His HbA1c is recently unstable, then glucose variability was investigated by CGM using 
FreeStyle Libre. The glucose pattern was different due to his lifestyle, including working day, off day, playing golf, 
respectively. The average glucose was 143-167 mg/dL and the estimated HbA1c was 7.1%, whereas HbA1c in 
outclinic was 8.1%, respectively. This report will hopefully become reference data for future research. 
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    Of these various diets, LCD has become more 
popular in recent years [4]. LCD was initially spread in 
Western countries by Dr. Bernstein and others [5]. 
Then, in Japan, authors and collaborators started LCD 
[6]. Successively, the clinical efficacy of LCD has been 
proven by various reports [7]. We have established the 
Japan LCD Promotion Association (JLCDPA) and 
developing several activities of LCD socially through 
papers, medical congress, seminars, and books [8]. 
From a research point of view, we performed LCD on 
thousands of patients and reported the effect of LCD, 
where the weight loss more than 10% or more was 
observed in 24%, and 5% or more was 59% [9]. 
There have been a variety of comparative discussions 
between LCD and CR [10]. 
 
    On the other hand, a recent topic concerning 
diabetic practice includes the prevalence of continuous 
glucose monitoring (CGM) for patients with T1DM and 
T2DM [11]. Among them, there were several reports 
for detecting hypoglycemia episodes [12]. In addition, a 
variety of beneficial points were revealed such as    
easy management, reliability, higher self-efficacy, 
simultaneous response, and other useful technology 
[13,14]. In fact, CGM has been frequently used in 
diabetic practice. Through our diabetes practice, 
authors have also already reported some cases with 
CGM evaluation in detail [15]. We have recently 
experienced an impressive male patient with T2DM, 
then a general case report and some related discussion 
will be described in this article. 
 
Case Report 
History of Present Illness: 
    The case is a 64-year-old male patient with T2DM, 
who has a medical history of 12 years of duration. As to 
diabetic therapy, he has been given insulin treatment 
for a long. About 1 year ago, his HbA1c was 8.2% at a 
rather higher level. Then, he changed his diet content 
from rice, bread, noodles to tofu (a product from 
soybeans with protein: fat: carbohydrate (P:F:C) = 
40:45:15) by our advice, and HbA1c has decreased to 
7.1% and 4kg of weight reduction in 2 months. His 
control status has not been in a satisfactory status, 
where HbA1c persisted approximately 7.4-8.5 % so far. 
To evaluate his glucose variability, the relationship 
between the daily profile of blood glucose and his daily 
activity was checked using FreeStyle Libre. 
 
Physical Examination: 
    He had unremarkable status in physical 
examination or no remarkable abnormalities of 
consciousness disorders from hypo- or hyperglycemia. 
His vital signs were normal, and his body mass index 
(BMI) has been approximately 24.9 kg/m
2
. He 
sometimes feels slight numbness in the extremities, 
which is supposed to be diabetic neuropathy. However, 
he was not pointed out to have retinopathy, 
nephropathy, or other significant macroangiopathic 
complications so far. 
 
Laboratory Exam: 
    The results of laboratory exams were shown as 
follows. Obtained standard biochemical data were AST 
14 U/mL, ALT 15 U/mL, r-GT 24 U/mL, BUN 19 
mg/dL, Cre 1.0 mg/dL, Uric Acid 5.5 mg/dL, HDL 54 
mg/dL, LDL 85 mg/dL, TG 119 mg/dL, WBC 4600 /μL, 
RBC 4.69 x 106/μL, Hb 14.8 g/dL, Plt 15.3 x 104/μL. 
Data related diabetes were HbA1c 8.1%, pre-prandial 
glucose 167 mg/dL.  
 
Medication: 
    He has been provided some medicine for T2DM, 
hypertension, and hyperlipidemia. The prescription 
includes Ipragliflozin L-Proline 50mg 1Tab, Valsartan 
80mg 1Tab, and Rosuvastatin 2.5mg 1 Tab . His blood 
pressure and lipids profile have been stable.  
 
Insulin Therapy: 
    He has been given insulin therapy for years by the 
method of multiple daily insulin injections (MDI). He 
was given two kinds of insulin three times a day. The 
pattern of his MDI in recent years is as follows: Novo 
rapid (Novo Nordisk) is provided 2 times a day just 
before breakfast and lunch, which is 6 units and 8 
units, respectively. Further, Humalog mix 50 is 




    In this case, his daily profile of blood glucose       
was investigated by the system of continuous     
glucose monitoring (CGM). His glucose  variability was 
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analyzed for 14 days. As regards to CGM, FreeStyle 
Libre (Abbott, USA) was applied [16]. It has been well-
known for its stable reliability for the measurement of 
changes in blood glucose [17]. It has shown beneficial 
predominance including trend accuracy, point 
accuracy, sensor stability, calibration, alarms, 
traceability, and time lag [18]. Furthermore, it shows 
satisfactory results for the guideline of the Clinical and 
Laboratory Standards Institute (CLSI) [19].  
 
    The case has taken tofu in the clinical course. These 
products were produced by Morinaga Milk Industry 
Co., Ltd., Japan. Their beneficial points include two 
aspects as follows: i) Long-life technology: Food and 
containers are sterilized separately, and aseptically 
filled without using preservatives. As a result, it 
enables long-term storage and can be stored at room 
temperature for 6.5 months (195 days). It is from the 
technology that has applied aseptic filling and 
packaging of milk for many years. ii) Paper pack with 6  
 
layers: Paper pack with high barrier property is used 
(Fig-1). By putting aluminum foil between the paper 
and polyethylene, it is difficult for air and oxygen to 




    This case was set on FreeStyle Libre for 14 days, and 
the daily profile of blood glucose was obtained. The 
results of the CGM were satisfactory and shown in  
Fig-2. Out of 14 days, glucose variability in 4 days were 
summarized on May 13, 16, 19, 24. He spent different 
daily activity in each day as follows. They are i) regular 
working day, and hyperglycemia is found after lunch 
period in the day, ii) no working day, and the patient 
kept still and had cakes in the afternoon, iii) regular 
working day, and it showed similar glucose profile to 
May 13, iv) patient played golf all day with normal 




















   
Fig-1: 
    Japanese tofu with less carbohydrate suitable for LCD. Silky tofu in blue color (left) and protein-rich tofu in yellow color 
(right). Both type show 290g Vs 297g in weight, 33:51:15 Vs 40:45:15 in PFC ratio, 7.5g Vs 7.2g, in carbohydrate, respectively. 
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    The average blood glucose in these days were 167 
mg/dL, 160 mg/dL, 165 mg/dL and 143 mg/dL, 
respectively. They are almost the same, but the profile 
pattern and the activity content are completely 
different. The software of FreeStyle Libre analyzed 
HbA1c value from the obtained data of blood glucose. 
The estimated HbA1c value was 7.1% or 54 mmol/mol. 
On the other hand, the HbA1c value in our outclinic 
during the period was 8.1% or 62 mmol/mol. Both 
data have some discrepancies between them. 
 
Discussion 
    As to the treatment of diabetes, there are currently 
standard guidelines. One is the 2019 “Consensus 
Statement by the American Association of Clinical 
Endocrinologists (AACE) and American College of 
Endocrinology (ACE) on the Comprehensive Type 2 
Diabetes Management Algorithm” [20], and another is 
the American Diabetes Association (ADA) Standards of 
Medical Care in Diabetes—2020 [21]. Their important 
points include adequate diet therapy and the 
combination of injection treatment for necessary cases 
with postprandial hyperglycemia. 
 
    The authors have continued clinical and research on 
the comparison of LCD and CR for years. Regarding 
LCD, we have proposed three kinds of practical diet. 
They are petite-LCD, standard-LCD, and super-LCD 
including carbohydrate ratio as 40%,  26%,  and  12%, 
 
respectively [22]. When a  patient  shows  obesity  and 
hyperglycemia and/or obesity to a higher degree, 
super-LCD would be recommended. When a patient 
shows these problems in a lower degree or on insulin 
treatment, petite-LCD or standard-LCD can be applied. 
In other words, three kinds of LCD can be useful due to 
the metabolic situation of the patient. In this case, he 
showed unsatisfactory diabetic control one year ago. 
He was on insulin treatment, then the recommended 
method would be not to drastically reduce 
carbohydrate, but to reduce carbohydrate moderately 
to some degree. 
 
    The patient has been the president of a trading 
company, and he has been mainly engaged in the 
management of milk and tofu. Formerly, his diet was 
close to CR. At that time, he was advised to change 
food intake from rice and bread to tofu instead. There 
is a principle concerning carbohydrates and increasing 
glucose in T2DM [23]. For example, 300 g of rice 
contains 108 g of carbohydrate, while 300 g of tofu 
contains 5 g of carbohydrate. According to the textbook 
of Harper's biochemistry, patients with T2DM raise 
blood glucose by 3 mg/dL by intake of 1g of 
carbohydrate. Therefore, rice 300 g increases 324 
mg/dL of blood glucose, while tofu 300 g increases 
only 15 mg/dL of blood glucose, showing a large 





    Daily profile of blood glucose by CGM using FreeStyle Libre 
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    Tofu has been one of the traditional Japanese food, 
which is a fermented product and made from soybeans 
[24]. Generally, tofu has been known as healthy food 
including much protein of soybeans and fewer 
carbohydrates. In this study, the case had two kinds of 
tofu, which are silky tofu and protein-rich tofu (Fig-1). 
Each product showed 290 g vs 297 g in weight per 
pack, 68 kcal vs 62 kcal / 100 g weight, 33:51:15 vs 
40:45:15 in PFC ratio, respectively. Calculating the 
carbohydrate amount in one pack of tofu, it has      
only 7.5 g vs 7.2 g, respectively. Consequently, by 
continuing to make the most of tofu for some period, it 
is expected that the LCD will be easy and successful. 
 
    Regarding the research on tofu, the quality of 
soybeans with high vs low protein content (44.8% vs 
39.1%) and with vs without 11X globulin polypeptide 
were investigated [25]. The results showed that 
soybeans with higher protein have smaller seeds which 
produced significantly firmer tofu gels associated with 
creamier color. There was a report concerning tofu 
consumption and arteriosclerosis [26]. Japanese men 
(n=652) were studied for the intake of soy food, 
fermented soy products, and brachial-ankle pulse wave 
velocity (baPWV) as an index of arterial stiffness. As a 
result, more consumption showed reduced arterial 
stiffness, suggesting the efficacy of isoflavone.  
 
    In this study, CGM was conducted successfully and 
blood glucose fluctuation pattern was perfectly 
observed. Regarding the four patterns shown in Fig-1, 
some discussion can be described in each day as 
follows: i) blood glucose value of 1200h-1500h was 
higher on a working day, suggesting the influence of 
the lunch, ii) glucose on 1200h-1700h was higher on 
non-working days, suggesting that the situation 
involves eating sweets and keeping stable with not 
moving, iii) similar diurnal fluctuation was observed as 
usual working days, iv) when playing golf, blood 
glucose remained normal level from 1200h to 2400h, 
suggesting the effect of exercise therapy for rather 
long. It is noteworthy that blood glucose had kept 
lower with the ideal level during the afternoon in iv) 
compared with that of i), ii), iii).  
 
    In one of our previous studies on CGM, precise, and 
detailed blood variability  was  observed.  The  example 
was that blood glucose was acutely dropped 3 hours 
after the first administration of sodium-glucose 
cotransporter 2 (SGLT2) inhibitor [27]. These data 
suggested remarkably useful evidence from a 
pathophysiological point of view.  
 
    Blood glucose levels measured by FreeStyle Libre are 
said to be lower than the actual levels. One of the 
reasons would be from the analysis mechanism that 
blood glucose level in the interstitial fluid has been 
calculated by the device. It is not the glucose value in 
the blood vessels. In previous reports, FreeStyle Libre 
measurements showed sufficient safety, accuracy, and 
tolerability [17]. However, data values measured with 
FreeStyle Libre generally tended to be low. As regards 
the degree of a discrepancy, the average ± standard 
deviation shows a large value of approximately -
43.4±20 mg/dL [28]. Furthermore, postprandial 
hyperglycemia may be underestimated [29]. For 
previous report, the mean absolute relative difference 
(MARD) glucose levels were 20.3%, 14.7%, and 9.6% 
in three glucose ranges (<72 mg/dL, 72-180 mg/dL, 
<181 mg/dL), respectively [30]. 
 
    In summary, glucose variability measured by CGM 
and discussion was described in this article. CGM has 
been more prevalent and useful [31]. Furthermore, it is 
expected to evolve into a compact and convenient 
device [32]. Furthermore, the clinical efficacy of LCD 
with practical usefulness of tofu were also introduced. 
This report will be hopefully some reference in diabetic 
practice and research in the future.  
 
Acknowledgement 
    The authors would like to appreciate all the related 
staff and the patient. 
 
Funding 
    The authors do not have any funding concerning 
our medical research. 
 
Conflicts of Interest 
    All authors have read and approved the final version 
of the manuscript. The authors have no conflicts of 
interest to declare. 
 
 
Manuscript no: 2582-0370-3-206                              Volume: 3      Issue: 3                                                                             211 




Citation: Yamashita H, Kato Y, Bando H, Kanazawa S, Tanaka M, Sueki E, Kanagawa H, Kawata T, Kawahito A, Aihara 
A, Miyashiro H. Relationship of Glucose Variability and Daily Lifestyle by Continuous Glucose Monitoring (CGM). Asp 
Biomed Clin Case Rep. 2020 Sept 20;3(3):206-12. 
 
References 
[1] IDF Diabetes Atlas. 9th Ed. International Diabetes 
Federation; 2019. Available from: 
https://diabetesatlas.org/en/ 
[2] Mauricio D, Alonso N, Gratacòs M. Chronic 
Diabetes Complications: The Need to Move beyond 
Classical Concepts. Trends Endocrinol Metab. 2020 
Apr;31(4):287-95. [PMID: 32033865] 
[3] Schwingshackl L, Chaimani A, Hoffmann G, 
Schwedhelm C, Boeing H. Impact of different dietary 
approaches on glycemic control and cardiovascular 
risk factors in patients with type 2 diabetes: a protocol 
for a systematic review and network meta-analysis. 
Syst Rev. 2017 Mar 20;6(1):57. [PMID: 28320464] 
[4] Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, 
Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, 
Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, 
Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, 
Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer 
MJ; Dietary Intervention Randomized Controlled Trial 
(DIRECT) Group. Weight loss with a low-carbohydrate, 
Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 
17;359(3):229-41. [PMID: 18635428] 
[5] Bernstein RK. Dr. Bernstein's diabetes solution: the 
complete guide to achieving normal blood sugars. New 
York: Little, Brown and company; 1997. 
[6] Ebe K, Ebe Y, Yokota S, Matsumoto T, Hashimoto 
M, Sakai Y. Low Carbohydrate diet (LCD) treated for 
three cases as diabetic diet therapy. Kyoto Medical 
Association Journal. 2004;51:125-29. 
[7] Muneta T, Kawaguchi E, Nagai Y, Matsumoto M, 
Ebe K, Watanabe H, Bando H. Ketone body elevation in 
placenta, umbilical cord, newborn and mother in 
normal delivery. Glycat Stress Res. 2016 Sep 
30;3(3):133-40. 
[8] Bando H, Muneta T, Bando M, Yonei Y. Effect of 
low carbohydrate diet on type 2 diabetic patients and 
usefulness of M-value. Diabetes Res Open J. 2017 Feb 
13;3(1):9-16. 
[9] Nakamura T, Kawashima T, Dobashi M, Narita A, 
Bando H. Effective Nutritional Guidance for Obesity by 
Low Carbohydrate Diet (LCD). Asp Biomed Clin Case 
Rep. 2019 Jan 27;2(s1):16-21. 
[10] Tay J, Thompson CH, Luscombe-Marsh ND, 
Wycherley TP, Noakes M, Buckley JD, Wittert GA, 
Yancy WS Jr, Brinkworth GD. Effects of an energy-
restricted low-carbohydrate, high unsaturated fat/low 
saturated fat diet versus a high-carbohydrate, low-fat 
diet in type 2 diabetes: A 2-year randomized clinical 
trial. Diabetes Obes Metab. 2018 Apr;20(4):858-71. 
[PMID: 29178536] 
[11] Slattery D, Choudhary P. Clinical Use of 
Continuous Glucose Monitoring in Adults with Type 1 
Diabetes. Diabetes Technol Ther. 2017 May;19(S2): 
S55-61. [PMID: 28541131] 
[12] Carlson A, Kanapka L, Miller K, Ahmann A, 
Chaytor N, Fox S, Kiblinger L, Kruger D, Levy C, Peters 
A, Rickels M. OR22-2 Exposure to Hypoglycemia in 
Older Adults with Type 1 Diabetes: Baseline 
Characteristics Using Continuous Glucose Monitoring 
Data. J Endocr Soc. 2019 Apr;3(Supplement_1)   
:OR22-2. 
[13] Messer LH, Cook PF, Tanenbaum ML, Hanes S, 
Driscoll KA, Hood KK. CGM Benefits and Burdens: Two 
Brief Measures of Continuous Glucose Monitoring. J 
Diabetes Sci Technol. 2019 Nov;13(6):1135-41. [PMID: 
30854886] 
[14] Taylor PJ, Thompson CH, Luscombe-Marsh ND, 
Wycherley TP, Wittert G, Brinkworth GD. Efficacy of 
Real-Time Continuous Glucose Monitoring to Improve 
Effects of a Prescriptive Lifestyle Intervention in Type 
2 Diabetes: A Pilot Study. Diabetes Ther. 2019 
Apr;10(2):509-22. [PMID: 30706365] 
[15] Bando H, Kato Y, Kanazawa S, Tanaka M, Sueki E, 
Kanagawa H, Kawata T, Kawahito A, Aihara A. Daily 
improvement of glucose variability by Continuous 
Glucose Monitoring (CGM). Recent Research in 
Endocrinology and Metabolic Disorder. 2020 Mar 
18;2(1):18-22. 
[16] Freestyle.FreeStyle Libre pro System. Professional 
Continuous Glucose Monitoring System. Abbott 
Diabetes Care. [Cited 2020 August]. Available from: 
https://www.myfreestyle.com/freestyle-libre-pro-
cgm-system 
[17] Edge J, Acerini C, Campbell F, Hamilton-Shield J, 
Moudiotis C, Rahman S, Randell T, Smith A, Trevelyan 
N. An alternative sensor-based method for glucose 
monitoring in children and young people with 
diabetes. Arch Dis Child. 2017 Jun;102(6):543-49. 
[PMID: 28137708] 
[18] Klonoff D, Bernhardt P, Ginsberg BH, Joseph J, 
Mastrototaro J, Parker DR, Vesper H, Vigersky R. 
Performance metrics for continuous interstitial glucose 
monitoring; approved guideline. CSLI. 2008;28(33). 
 
 
Keywords: Low Carbohydrate Diet (LCD), Continuous Glucose Monitoring (CGM), FreeStyle Libre, Japan LCD 
Promotion Association (JLCDPA), Tofu, Soybeans 
Manuscript no: 2582-0370-3-206                              Volume: 3      Issue: 3                                                                             212 




Citation: Yamashita H, Kato Y, Bando H, Kanazawa S, Tanaka M, Sueki E, Kanagawa H, Kawata T, Kawahito A, Aihara 
A, Miyashiro H. Relationship of Glucose Variability and Daily Lifestyle by Continuous Glucose Monitoring (CGM). Asp 
Biomed Clin Case Rep. 2020 Sept 20;3(3):206-12. 
 
[19] Slattery D, Choudhary P. Clinical Use of 
Continuous Glucose Monitoring in Adults with Type 1 
Diabetes. Diabetes Technol Ther. 2017 May;19(S2): 
S55-61. [PMID: 28541131] 
[20] Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, 
Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo 
RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, 
Grunberger G, Handelsman Y, Hirsch IB, Jellinger PS, 
McGill JB, Mechanick JI, Rosenblit PD, Umpierrez GE. 
Consensus Statement by the American Association of 
Clinical Endocrinologists and American College of 
Endocrinology on the Comprehensive Type 2 Diabetes 
Management Algorithm - 2019 Executive Summary. 
Endocr Pract. 2019 Jan;25(1):69-100. [PMID: 
30742570] 
[21] American Diabetes Association. 9. Pharmacologic 
Approaches to Glycemic Treatment: Standards of 
Medical Care in Diabetes-2020. Diabetes Care. 2020 
Jan;43(Suppl 1):S98-10. [PMID: 31862752] 
[22] Bando H, Ebe K, Muneta T, Bando M, Yonei Y. 
Clinical effect of low carbohydrate diet (LCD): Case 
report. Diabetes Case Rep. 2017 Jun 10;2(2):124. 
[23] Bender DA, Botham KM, Kennelly PJ, Rodwell 
VW, Weil PA. Harper’s Illustrated Biochemistry. 31st 
edition. New York: McGraw-Hill; 2018. 
[24] Zhu Y, Wang Z, Zhang L. Optimization of lactic 
acid fermentation conditions for fermented tofu whey 
beverage with high-isoflavone aglycones. LWT. 2019 
Aug 1;111:211-17. 
[25] James AT, Yang A. Interactions of protein content 
and globulin subunit composition of soybean proteins 
in relation to tofu gel properties. Food Chem. 2016 Mar 
1;194:284-89. [PMID: 26471556] 
[26] Uemura H, Katsuura-Kamano S, Nakamoto M, 
Yamaguchi M, Fujioka M, Iwasaki Y, Arisawa K. 
Inverse association between soy food consumption, 
especially fermented soy products intake and soy 
isoflavone, and arterial stiffness in Japanese men. 
Scientific reports. 2018 Jun 25;8(1):1-9. 
[27] Ebe K, Bando H, Muneta T, Bando M, Yonei Y. 
Remarkable Improvement of Glucose Variability by 
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors 
using Continuous Glucose Monitoring (CGM). Diabetes 
Case Rep. 2019 Jan 28;4(1):1-5. 
[28] Schierenbeck F, Franco-Cereceda A, Liska J. 
Accuracy of 2 Different Continuous Glucose Monitoring 
Systems in Patients Undergoing Cardiac Surgery. J 
Diabetes Sci Technol. 2017 Jan;11(1):108-16. [PMID: 
27257168] 
[29] Fokkert MJ, van Dijk PR, Edens MA, Abbes S, de 
Jong D, Slingerland RJ, Bilo HJ. Performance of the 
FreeStyle Libre Flash glucose monitoring system in 
patients with type 1 and 2 diabetes mellitus. BMJ Open 
Diabetes Res Care. 2017 Feb 17;5(1):e000320. [PMID: 
28243449] 
[30] Ólafsdóttir AF, Attvall S, Sandgren U, Dahlqvist S, 
Pivodic A, Skrtic S, Theodorsson E, Lind M. A Clinical 
Trial of the Accuracy and Treatment Experience of the 
Flash Glucose Monitor FreeStyle Libre in Adults with 
Type 1 Diabetes. Diabetes Technol Ther. 2017 
Mar;19(3):164-72. [PMID: 28263665] 
[31] American Diabetes Association. 7. Diabetes 
Technology: Standards of Medical Care in Diabetes-
2019. Diabetes Care. 2019 Jan;42(Suppl 1):S71-80. 
[PMID: 30559233] 
[32] Kebede MM, Schuett C, Pischke CR. The Role of 
Continuous Glucose Monitoring, Diabetes Smartphone 
Applications, and Self-Care Behavior in Glycemic 
Control: Results of a Multi-National Online Survey. J 
Clin Med. 2019 Jan 17;8(1):109. [PMID: 30658463] 
 
